MYCOGEN SEEDS ANNOUNCES NEW STRATEGIC DIRECTION;
COMPANY TO FOCUS
ON CORE PRODUCT LINE AND CAPTURE SYNERGIES WITH
DOW AGROSCIENCES LLC- April 23, 1999
Mycogen Seeds today announced its intent to be one of the top three brands in select
crops, a strategic redirection that positions the company well for the future. The
change focuses Mycogen's resources on key product lines and market segments where it has a
demonstrated competitive edge, and aligns its operation with those of Dow AgroSciences.
ALL MYCOGEN SEEDS HYBRIDS APPROVED FOR IMPORTATION
INTO THE EUROPEAN
UNION - April 21, 1999
Farmers planting Bt corn from Mycogen Seeds this spring can rest assured their
genetically modified corn crop will be marketable in the European Union.
MYCOGEN SEEDS NAMES KLINEFELTER NEW PLANT MANAGER -
April 21, 1999
Craig Klinefelter recently was named plant manager of Mycogen Seeds in York, Nebraska
MYCOGEN SEEDS NAMES MAACK NEW PLANT MANAGER -
April 6, 1999
Greg Maack recently was promoted to plant and contract production manager of Mycogen Seeds
in
Hastings, Minnesota.
MYCOGEN SEEDS UPGRADES OLIVIA PRODUCTION PLANT TO
INCLUDE WORLD-CLASS SUNFLOWER PROCESSING FACILITY - April 6, 1999
Mycogen Seeds, the leading sunflower seed producer in the United States, will further its
commitment to global
sunflower seed production with the completion of upgrades and expansions to its Olivia,
Minn., production plant
this summer.
DOW AGROSCIENCES OUTLINES
GLYPHOSATE STRATEGY January 19, 1999
Dow AgroSciences LLC today outlined its glyphosate strategy, saying it plans to become a
major player in the global glyphosate market and that glyphosate will be a key product for
the company.
MONSANTO AND DOW AGROSCIENCES
ANNOUNCE AGREEMENT ON GLYPHOSATE AND ROUNDUP READY CROPS January 19, 1999
Dow AgroSciences LLC and Monsanto Company today announced a global, multi-year toll
manufacturing agreement that also licenses Dow AgroSciences the rights to Monsanto's
glyphosate herbicide registration data. The agreement will allow Dow AgroSciences to
register its own brand of glyphosate herbicide for sale globally. However, Dow
AgroSciences will not be able to reference Monsanto data when registering its products for
use in Japan.
DOW AGROSCIENCES INTRODUCES
NUTRITIONALLY ENHANCED CORN January 19, 1999
Dow AgroSciences has unveiled a new genetics package for corn hybrids going into the feed
grains market.
NUSUN™ MAY HELP BOOST
DOMESTIC SUNFLOWER OIL MARKET; APPEALS TO HEALTH-CONSCIOUS CONSUMERS December 18,
1998
NuSun™ sunflower oil could become the next cooking oil giant. A promising alternative
for U.S. sunflower growers, oil produced from NuSun hybrids is low in saturated fats and
doesn't require hydrogenation - a necessary food-processing step in the production of many
cooking oils. Hydrogenation creates trans-fatty acids, which have been linked to
heart-related diseases.
PLANTING BIN-RUN SEED IS
RISKY ECONOMICALLY, LEGALLY December 16, 1998
In light of today's poor market prices, soybean growers may be tempted to save some of
their 1998 soybean crop for 1999 planting. Or, they may consider buying
"brown-bag" seed (grower-saved seed sold to another grower) for next year's
crop. These options are extremely risky, from both a financial and legal perspective.
DEMEGEN LICENSES TRANSGENIC
CROP TECHNOLOGY TO DOW AGROSCIENCES December 9, 1998
Demegen, Inc. and Dow AgroSciences LLC announced today the expansion of a license
agreement to include technologies to increase the nutrition quality and protein content in
food and feed crops. The previous license agreement between Demegen and Mycogen had been
specific to technologies for the development of disease resistant crops.
RESEARCHER SAYS PLAN NOW FOR
ECB THREAT NEXT YEAR December 3, 1998
Growers shouldn't be fooled by low levels of European corn borer (ECB) this past season,
according to Paul Bystrak, research scientist with Mycogen Seeds. Any insect presence this
year can lead to serious infestations the next, he says.
TEN INTEGRATED STEPS TO
SUCCESS
Remarks by Michael J. Muston, Mycogen Seeds President, at the Integrated Crop Management
Conference at Iowa State University.
SURVIVING THE HERE AND NOW
– THRIVING IN THE FUTURE
Remarks by Michael J. Muston, Mycogen Seeds President, to Minnesota Agri-Growth Council,
Inc. at their 1998 Annual Meeting.
CORN GROWERS ADVISED TO
PRACTICE Bt RESISTANCE MANAGEMENT October 30, 1998
Farmers who grow European corn borer (ECB)-resistant corn hybrids should implement
resistance management practices to preserve the revolutionary Bacillus thuringiensis (Bt)
technology, says Paul Bystrak, a research scientist in trait development with Mycogen
Seeds.
DOW SUBSIDIARY PURCHASES
MYCOGEN SHARES IN TENDER OFFER
The Dow Chemical Company announced today that Dow’s wholly-owned subsidiary
AgroSciences Acquisition Inc. has purchased all shares of common stock of Mycogen
Corporation (NASDAQ: "MYCO") which were validly tendered in response to its
$28.00 per share tender offer.
AGRIBIOTECH, INC. AND
MYCOGEN TO DEVELOP INSECT RESISTANT ALFALFA USING Bt TECHNOLOGY
Dr. Johnny R. Thomas, Chairman and Chief Executive Officer, AgriBioTech, Inc. (NASDAQ
National Market: ABTX) announced today that AgriBioTech and Mycogen (NASDAQ National
Market: MYCO) have signed a letter of intent to jointly develop insect-resistant alfalfa
varieties.
MYCOGEN EXPANDS PRESENCE IN
BRAZIL WITH ACQUISITION OF TWO SEED COMPANIES
Mycogen Corporation has signed definitive agreements to expand its presence in the large
and strategically important Brazilian seed market by acquiring two companies that develop
and market seed products for corn and sorghum.
DOW TO ACQUIRE ALL
OUTSTANDING MYCOGEN SHARES
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, and Mycogen
Corporation (NASDAQ: MYCO) today announced that they have signed a definitive agreement
for Dow AgroSciences to acquire all of the outstanding shares of Mycogen that it does not
already own.
MYCOGEN SEEDS TO CO-MARKET
TMF® SILAGE CORN HYBRIDS
Mycogen Corporation’s Mycogen Seeds unit and Croplan Genetics, the seed marketing
division of Land O’Lakes, Inc., have signed a definitive agreement to co-market TMF® brand corn silage hybrids developed by Mycogen.
FORAGE GENETICS, MYCOGEN,
NEW MEXICO STATE ANNOUNCE ALFALFA RESEARCH AGREEMENT
Forage Genetics, Mycogen Corporation and New Mexico State University have formed a
three-way research and development collaboration designed to improve the forage quality of
alfalfa.
MYCOGEN SEEDS TO EXPAND
DISTRIBUTION OF Bt CORN
Mycogen Corporation’s Mycogen Seeds unit and Novartis Seeds have amended a
cross-license agreement to allow both companies to market seed corn with Bacillus
thuringiensis (Bt)-based insect-resistance broadly through other seed companies.
MYCOGEN WINS Bt PATENT
INFRINGEMENT SUIT; JURY DECLARES MONSANTO PATENT INVALID
A Federal District Court jury ruled today that a patent held by Monsanto Company that
covers technology for modifying Bacillus thuringiensis (Bt) to make plants
insect-resistant is invalid.
JUDGE UPHOLDS MYCOGEN’S
$174.9 MILLION DAMAGE AWARD IN SEED TECHNOLOGY DISPUTE WITH MONSANTO
In a written ruling issued May 21, 1998, Superior Court Judge Herbert B. Hoffman, who
presided over the trial, stated that "Monsanto has failed to present any basis for an
order granting judgment notwithstanding the verdict, nor has Monsanto shown any basis for
an order granting a new trial. There is substantial evidence supporting the jury’s
verdict."
MYCOGEN TO ACQUIRE BRAZILIAN SEED
CORN COMPANY
Mycogen Corporation has signed definitive agreements to acquire Dinamilho Carol Productos
Agricolas Ltda., a leading Brazilian developer and marketer of high-yielding hybrid seed
corn products.
JURY AWARDS $174.9 MILLION IN
DAMAGES TO MYCOGEN IN SEED TECHNOLOGY DISPUTE WITH MONSANTO
A Superior Court jury has awarded $174.9 million in damages to Mycogen Corporation in a
breach of contract suit against Monsanto Company arising from Monsanto’s delay in
fulfilling the terms of option agreements to license crop enhancement technology to
Mycogen.
MYCOGEN GRANTS NON-EXCLUSIVE
LICENSE TO AXIS GENETICS FOR HUMAN HEALTH APPLICATIONS OF EDIBLE VACCINE TECHNOLOGY
Mycogen Corporation has granted a non-exclusive license to Axis Genetics PLC, Brabraham,
Cambridge, U.K., for human health applications of technology to genetically alter plants
to produce and deliver edible vaccines.
MYCOGEN FILES MOTIONS TO SET ASIDE
JURY VERDICT IN DELAWARE PATENT INFRINGEMENT SUIT
Attorneys for Mycogen Corporation filed motions in Federal District Court here, requesting
that the court set aside a February 5, 1998, jury verdict that two patents held by Mycogen
were not valid.
DELAWARE FEDERAL COURT VERDICT
INVALIDATES MYCOGEN BT PATENTS
A jury in Federal District Court today ruled that two U.S. patents held by Mycogen
Corporation that cover Bacillus thuringiensis (Bt) gene synthesis technology used to make
plants insect-resistant are invalid.
BT TECHNOLOGY PATENT BOLSTERS
MYCOGEN’S POSITION FOR INSECT-RESISTANT PLANTS
Mycogen Corporation today received a U.S. patent covering shortened Bacillus thuringiensis
(Bt) gene sequences that are used to develop insect resistant plants and biopesticides.
MYCOGEN LICENSES
DISEASE-RESISTANCE TECHNOLOGY FOR PLANTS
Mycogen Corporation has obtained exclusive worldwide rights for application of synthetic
peptide technology to develop transgenic disease-resistant varieties of several major
crops through a license agreement with Demeter Biotechnologies, Limited.
MYCOGEN OBTAINS HUMAN AND ANIMAL
HEALTH RIGHTS FOR GENETICALLY ALTERED PLANTS THAT PRODUCE EDIBLE VACCINES November
3, 1997
SAN DIEGO, Calif. – Mycogen Corporation has entered into license agreements with
Washington University, St. Louis, Mo., for exclusive commercial rights to human and animal
health applications of technology to genetically alter plants to produce and deliver
edible vaccines.
Copyright © Mycogen Corporation 1998